Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 332 followers

Latest posts

Last updated about 10 hours ago

Agenda of the PRAC meeting 8-11 June 2026

about 10 hours ago

Agenda of the PRAC meeting 8-11 June 2026

EMEA-001563-PIP02-15-M01

about 10 hours ago

EMEA-001563-PIP02-15-M01

Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 2, Status: Authorised

about 10 hours ago

Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Alecensa, alectinib, Date of authorisation: 16/02/2017, Revision: 18, Status: Authorised

about 10 hours ago

Human medicines European public assessment report (EPAR): Alecensa, alectinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Vyjuvek, beremagene geperpavec, Date of authorisation: 23/04/2025, Revision: 2, Status: Authorised

about 10 hours ago

Human medicines European public assessment report (EPAR): Vyjuvek, beremagene geperpavec, Date of...

Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 53, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation...

Applications for new human medicines under evaluation: June 2026

about 12 hours ago

Applications for new human medicines under evaluation: June 2026

Scientific publications

about 12 hours ago

Scientific publications

Presentations - EnprEMA& ACT EU workshop on paediatric clinical trials

about 13 hours ago

Presentations - EnprEMA& ACT EU workshop on paediatric clinical trials

Data protection notice for legal entity and bank account validation regarding payments

about 13 hours ago

Data protection notice for legal entity and bank account validation regarding payments

Agenda - Clinical trials information system information day webinar

about 15 hours ago

Agenda - Clinical trials information system information day webinar

Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 26, Status: Authorised

about 15 hours ago

Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of...